Understanding the benefits and challenges of first‐line cyclin‐dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women

Citation:
Azim, H. A., S. Dawood, N. El‐Saghir, L. Kassem, and H. A. Azim, Understanding the benefits and challenges of first‐line cyclin‐dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women, : John Wiley & Sons, Ltd (10.1111), Submitted.

Abstract:

n/a

Notes:

n/a

Tourism